Novartis (NVS)
(Delayed Data from NYSE)
$97.44 USD
-1.62 (-1.64%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $97.41 -0.03 (-0.03%) 7:58 PM ET
3-Hold of 5 3
B Value D Growth A Momentum C VGM
Earnings News For NVS
-
Novartis (NVS) Q1 Earnings, Sales Beat, Guidance Raised
-
Novartis: Q1 Earnings Snapshot
-
Novartis (NVS) to Report Q1 Earnings: What to Expect?
-
Novartis (NVS) Q4 Earnings Miss on Higher Costs, Sales Lag
-
Novartis: Q4 Earnings Snapshot
-
Novartis (NVS) to Report Q4 Earnings: Is a Beat in Store?
-
Novartis (NVS) Tops Q3 Earnings, Ups Operating Income View
-
Novartis: Q3 Earnings Snapshot
-
Novartis (NVS) to Report Q3 Earnings: What's in the Offing?
-
Novartis (NVS) Q2 Earnings & Revenues Top, Guidance Raised
-
Novartis (NVS) to Report Q2 Earnings: Is a Beat in Store?
-
Novartis (NVS) Tops on Q1 Earnings & Revenues, Ups View
-
Novartis (NVS) Q4 Earnings Top, Revenues Miss Estimates
-
Novartis (NVS) Q3 Earnings Top, Revenues Miss Estimates
-
What's in Store for Novartis (NVS) This Earnings Season?
-
Novartis (NVS) Q2 Earnings Beat, Revenues Miss Estimates
-
Novartis (NVS) Beats on Q1 Earnings, Sandoz Posts Growth
-
Novartis (NVS) Q4 Earnings & Sales Miss, Sandoz Review Ongoing
-
Novartis (NVS) Q3 Earnings Beat, Sandoz Under Strategic Review
-
Novartis' (NVS) Q2 Earnings Top Estimates as Businesses Recovers
-
Novartis (NVS) Q1 Earnings & Sales Miss Estimates on COVID-19 Woes
-
Novartis (NVS) Misses on Q4 Earnings, Issues Grim 2021 Outlook
-
Novartis' (NVS) Q3 Earnings Surpass Estimates, Sales Miss
-
Novartis' (NVS) Q2 Earnings Surpass Estimates, Sales Miss
-
Novartis (NVS) Q1 Earnings and Revenues Surpass Estimates